Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52572) 52572
Book Chapter (198) 198
Book / eBook (103) 103
Magazine Article (18) 18
Dissertation (7) 7
Web Resource (5) 5
Conference Proceeding (4) 4
Government Document (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47919) 47919
science & technology (45957) 45957
life sciences & biomedicine (41496) 41496
female (26682) 26682
oncology (22921) 22921
male (18828) 18828
middle aged (16483) 16483
cancer (15735) 15735
adult (14090) 14090
tumors (13718) 13718
aged (12930) 12930
biological and medical sciences (10813) 10813
medical sciences (10247) 10247
animals (9931) 9931
prognosis (9232) 9232
research (8772) 8772
care and treatment (7080) 7080
chemotherapy (6605) 6605
health aspects (6568) 6568
breast cancer (6271) 6271
surgery (6201) 6201
analysis (6141) 6141
risk factors (6102) 6102
genetic aspects (5865) 5865
cell line, tumor (5841) 5841
mice (5739) 5739
hematology (5546) 5546
medicine & public health (5506) 5506
treatment outcome (5363) 5363
gene expression (5248) 5248
research article (5230) 5230
aged, 80 and over (5089) 5089
metastasis (5059) 5059
mutation (5018) 5018
pathology (4967) 4967
adolescent (4516) 4516
medicine (4516) 4516
science & technology - other topics (4419) 4419
multidisciplinary sciences (4271) 4271
neoplasm staging (4188) 4188
child (4034) 4034
patients (4011) 4011
cell biology (4005) 4005
immunohistochemistry (3996) 3996
diagnosis (3903) 3903
retrospective studies (3878) 3878
abridged index medicus (3640) 3640
proteins (3557) 3557
cancer therapies (3547) 3547
development and progression (3527) 3527
science (3335) 3335
young adult (3280) 3280
medical prognosis (3172) 3172
gene expression regulation, neoplastic (3162) 3162
biochemistry & molecular biology (3132) 3132
breast neoplasms - pathology (3035) 3035
medical research (3027) 3027
follow-up studies (2991) 2991
apoptosis (2989) 2989
studies (2975) 2975
antineoplastic agents - therapeutic use (2914) 2914
cancer research (2771) 2771
neoplasms. tumors. oncology. including cancer and carcinogens (2771) 2771
genetics (2647) 2647
survival analysis (2624) 2624
disease-free survival (2616) 2616
medicine, research & experimental (2608) 2608
research & experimental medicine (2606) 2606
genetics & heredity (2603) 2603
colorectal cancer (2596) 2596
antineoplastic combined chemotherapy protocols - therapeutic use (2582) 2582
stem cells (2556) 2556
breast neoplasms - genetics (2554) 2554
polymerase chain reaction (2476) 2476
usage (2438) 2438
child, preschool (2437) 2437
genes (2415) 2415
hematology, oncology and palliative medicine (2403) 2403
ovarian cancer (2357) 2357
survival rate (2341) 2341
biomarkers, tumor - genetics (2319) 2319
immunotherapy (2317) 2317
physiological aspects (2293) 2293
biomarkers (2289) 2289
oncology, experimental (2288) 2288
combined modality therapy (2255) 2255
survival (2221) 2221
signal transduction (2112) 2112
metastases (2111) 2111
immunology (2095) 2095
kinases (2093) 2093
leukemia (2082) 2082
deoxyribonucleic acid--dna (2080) 2080
epidemiology (2025) 2025
prospective studies (2003) 2003
neoplasms (1986) 1986
pediatrics (1978) 1978
biology (1965) 1965
neurosciences & neurology (1961) 1961
disease progression (1956) 1956
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (24) 24
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (12) 12
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Circulation Desk (3) 3
Lakeridge Health Sciences - Oshawa (1) 1
Lakeridge Health Sciences - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52655) 52655
Japanese (147) 147
Chinese (129) 129
German (86) 86
French (65) 65
Russian (40) 40
Spanish (30) 30
Portuguese (29) 29
Polish (17) 17
Norwegian (16) 16
Italian (15) 15
Hungarian (9) 9
Czech (8) 8
Danish (7) 7
Dutch (7) 7
Turkish (5) 5
Serbian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Icelandic (1) 1
Korean (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer
by Blakely, Collin M and Pazarentzos, Evangelos and Olivas, Victor and Asthana, Saurabh and Yan, Jenny Jiacheng and Tan, Irena and Hrustanovic, Gorjan and Chan, Elton and Lin, Luping and Neel, Dana S and Newton, William and Bobb, Kathryn L and Fouts, Timothy R and Meshulam, Jeffrey and Gubens, Matthew A and Jablons, David M and Johnson, Jeffrey R and Bandyopadhyay, Sourav and Krogan, Nevan J and Bivona, Trever G
Cell reports (Cambridge), ISSN 2211-1247, 04/2015, Volume 11, Issue 1, pp. 98 - 110
Life Sciences & Biomedicine | Science & Technology | Cell Biology | Lung Neoplasms - drug therapy | RNA-Binding Proteins - genetics | Adenocarcinoma - pathology | Adenocarcinoma of Lung | Apoptosis - drug effects | Humans | TNF Receptor-Associated Factor 2 - genetics | ErbB Receptors - genetics | Lung Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Molecular Targeted Therapy | Proto-Oncogene Proteins c-akt - genetics | Nuclear Pore Complex Proteins - genetics | I-kappa B Kinase - metabolism | Epoxy Compounds - administration & dosage | Adenocarcinoma - genetics | Gene Expression Regulation, Neoplastic - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Lung Neoplasms - genetics | Cell Survival - drug effects | NF-kappa B - antagonists & inhibitors | ErbB Receptors - antagonists & inhibitors | Nuclear Pore Complex Proteins - metabolism | TNF Receptor-Associated Factor 2 - metabolism | Cyclohexanones - administration & dosage | I-kappa B Kinase - genetics | Adenocarcinoma - drug therapy | Drug Resistance, Neoplasm - genetics | NF-kappa B - genetics | Signal Transduction - drug effects | Cell Line, Tumor | RNA-Binding Proteins - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: Results of the United Kingdom MRC AML-15 trial
by Liu Yin, John A and O'Brien, Michelle A and Hills, Robert K and Daly, Sarah B and Wheatley, Keith and Burnett, Alan K
Blood, ISSN 0006-4971, 10/2012, Volume 120, Issue 14, pp. 2826 - 2835
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Chromosomes, Human, Pair 8 - genetics | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Neoplasm Recurrence, Local - mortality | Young Adult | Neoplasm, Residual - diagnosis | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Neoplasm, Residual - mortality | Real-Time Polymerase Chain Reaction | Risk Assessment | RNA, Messenger - genetics | Survival Rate | Neoplasm Recurrence, Local - diagnosis | Chromosomes, Human, Pair 21 - genetics | Reverse Transcriptase Polymerase Chain Reaction | Neoplasm, Residual - genetics | Leukemia, Myeloid, Acute - mortality | RUNX1 Translocation Partner 1 Protein | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Oncogene Proteins, Fusion - genetics | Adolescent | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Core Binding Factor Alpha 2 Subunit - genetics | Translocation, Genetic - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Assessment of Minimal Residual Disease in Standard-Risk AML
by Ivey, Adam and Hills, Robert K and Simpson, Michael A and Jovanovic, Jelena V and Gilkes, Amanda and Grech, Angela and Patel, Yashma and Bhudia, Neesa and Farah, Hassan and Mason, Joanne and Wall, Kerry and Akiki, Susanna and Griffiths, Michael and Solomon, Ellen and McCaughan, Frank and Linch, David C and Gale, Rosemary E and Vyas, Paresh and Freeman, Sylvie D and Russell, Nigel and Burnett, Alan K and Grimwade, David and UK National Cancer Research Institute AML Working Group
The New England journal of medicine, ISSN 0028-4793, 02/2016, Volume 374, Issue 5, pp. 422 - 433
Recurrence | Prognosis | Humans | Risk Factors | Transcriptome | Molecular Sequence Data | Nuclear Proteins - metabolism | Gene Expression Profiling | Reverse Transcriptase Polymerase Chain Reaction | Neoplasm, Residual - genetics | Exome | Base Sequence | DNA, Neoplasm - analysis | Mutation | Nuclear Proteins - genetics | Leukemia, Myeloid, Acute - genetics | Regression (Disease) | Research | Gene mutations | Biological markers | Health risk assessment | Risk factors | Myeloid leukemia | Leukemia | Genes | Clinical trials | Minimal residual disease | Quantitation | Multivariate analysis | Patients | Polymerase chain reaction | Genetic markers | Chemotherapy | Medical prognosis | Remission | Acute myeloid leukemia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
by Spina, Valeria and Bruscaggin, Alessio and Cuccaro, Annarosa and Martini, Maurizio and Trani, Martina Di and Forestieri, Gabriela and Manzoni, Martina and Condoluci, Adalgisa and Arribas, Alberto and Terzi-Di-Bergamo, Lodovico and Locatelli, Silvia Laura and Cupelli, Elisa and Ceriani, Luca and Moccia, Alden A and Stathis, Anastasios and Nassi, Luca and Deambrogi, Clara and Diop, Fary and Guidetti, Francesca and Cocomazzi, Alessandra and Annunziata, Salvatore and Rufini, Vittoria and Giordano, Alessandro and Neri, Antonino and Boldorini, Renzo and Gerber, Bernhard and Bertoni, Francesco and Ghielmini, Michele and Stüssi, Georg and Santoro, Armando and Cavalli, Franco and Zucca, Emanuele and Larocca, Luigi Maria and Gaidano, Gianluca and Hohaus, Stefan and Carlo-Stella, Carmelo and Rossi, Davide
Blood, ISSN 0006-4971, 05/2018, Volume 131, Issue 22, pp. 2413 - 2425
Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Circulating Tumor DNA - genetics | Dacarbazine - therapeutic use | Hodgkin Disease - genetics | Hodgkin Disease - pathology | Humans | Neoplasm Recurrence, Local - drug therapy | Antineoplastic Agents - therapeutic use | STAT6 Transcription Factor - genetics | Antineoplastic Agents - administration & dosage | Vinblastine - administration & dosage | Vinblastine - therapeutic use | Bleomycin - therapeutic use | Immunotherapy | Hodgkin Disease - drug therapy | Reed-Sternberg Cells - drug effects | Tumor Cells, Cultured | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Clonal Evolution - drug effects | Genotype | Bleomycin - administration & dosage | Neoplasm, Residual - blood | Neoplasm, Residual - genetics | Reed-Sternberg Cells - metabolism | Reed-Sternberg Cells - pathology | Hodgkin Disease - blood | Mutation - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm, Residual - drug therapy | High-Throughput Nucleotide Sequencing | Circulating Tumor DNA - blood | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Molecular Minimal Residual Disease in Acute Myeloid Leukemia
by Jongen-Lavrencic, Mojca and Grob, Tim and Hanekamp, Diana and Kavelaars, François G and al Hinai, Adil and Zeilemaker, Annelieke and Erpelinck-Verschueren, Claudia A.J and Gradowska, Patrycja L and Meijer, Rosa and Cloos, Jacqueline and Biemond, Bart J and Graux, Carlos and van Marwijk Kooy, Marinus and Manz, Markus G and Pabst, Thomas and Passweg, Jakob R and Havelange, Violaine and Ossenkoppele, Gert J and Sanders, Mathijs A and Schuurhuis, Gerrit J and Löwenberg, Bob and Valk, Peter J.M
The New England journal of medicine, ISSN 0028-4793, 03/2018, Volume 378, Issue 13, pp. 1189 - 1199
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Prognosis | Humans | Middle Aged | Proportional Hazards Models | Hematopoiesis - genetics | Male | DNA Mutational Analysis - methods | Remission Induction | Neoplasm, Residual - genetics | Leukemia, Myeloid, Acute - mortality | Young Adult | Flow Cytometry | Neoplasm, Residual - diagnosis | Adolescent | Survival Analysis | Adult | Female | Aged | DNA, Neoplasm - analysis | High-Throughput Nucleotide Sequencing | Mutation | Leukemia, Myeloid, Acute - genetics | Relapse | Research | Risk factors | Cancer cells | Cancer | Flow cytometry | Hematology | Myeloid leukemia | Leukemia | Minimal residual disease | Multivariate analysis | Cancer therapies | Survival | Patients | Hemopoiesis | Chemotherapy | Gene frequency | Medical prognosis | Bone marrow | Remission | Death | Blood diseases | Acute myeloid leukemia | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
by Tie, Jeanne and Wang, Yuxuan and Tomasetti, Cristian and Li, Lu and Springer, Simeon and Kinde, Isaac and Silliman, Natalie and Tacey, Mark and Wong, Hui-Li and Christie, Michael and Kosmider, Suzanne and Skinner, Iain and Wong, Rachel and Steel, Malcolm and Tran, Ben and Desai, Jayesh and Jones, Ian and Haydon, Andrew and Hayes, Theresa and Price, Tim J and Strausberg, Robert L and Diaz, Luis A and Papadopoulos, Nickolas and Kinzler, Kenneth W and Vogelstein, Bert and Gibbs, Peter
Science translational medicine, ISSN 1946-6234, 07/2016, Volume 8, Issue 346, pp. 346ra92 - 346ra92
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Circulating Tumor DNA - analysis | Colonic Neoplasms - genetics | Prospective Studies | Circulating Tumor DNA - genetics | Neoplasm, Residual - surgery | Humans | Proportional Hazards Models | Neoplasm, Residual - blood | Neoplasm, Residual - genetics | Colonic Neoplasms - surgery | Disease-Free Survival | Colonic Neoplasms - blood | Neoplasm Recurrence, Local - genetics | Neoplasm Staging | Neoplasm Recurrence, Local - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Liquid biopsy and minimal residual disease — latest advances and implications for cure
by Pantel, Klaus and Alix-Panabières, Catherine
Nature reviews. Clinical oncology, ISSN 1759-4774, 07/2019, Volume 16, Issue 7, pp. 409 - 424
Life Sciences & Biomedicine | Oncology | Science & Technology | Molecular evolution | Biopsy | Therapeutic applications | Minimal residual disease | Patients | Deoxyribonucleic acid--DNA | Cancer | Tumors | Metastases | Index Medicus | Life Sciences | Genetics | Cell-Free Nucleic Acids/genetics | Neoplastic Cells, Circulating/pathology | Neoplasm Residual/diagnosis | Human genetics | Precision Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease
by Travnickova, Jana and Wojciechowska, Sonia and Khamseh, Ava and Gautier, Philippe and Brown, Daniel V and Lefevre, Thomas and Brombin, Alessandro and Ewing, Ailith and Capper, Amy and Spitzer, Michaela and Dilshat, Ramile and Semple, Colin A and Mathers, Marie E and Lister, James A and Steingrimsson, Eirikur and Voet, Thierry and Ponting, Chris P and Patton, E. Elizabeth
Cancer research (Chicago, Ill.), ISSN 0008-5472, 11/2019, Volume 79, Issue 22, pp. 5769 - 5784
Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasm, Residual - pathology | Neural Crest - pathology | Gene Expression Profiling - methods | Melanoma - pathology | Neoplasm, Residual - genetics | Zebrafish - genetics | Neoplasm Recurrence, Local - pathology | Drug Resistance - genetics | Animals | Melanoma - genetics | Proto-Oncogene Proteins B-raf - genetics | Melanocytes - pathology | Stem Cells - pathology | Neoplasm Recurrence, Local - genetics | Transcription, Genetic - genetics | Microphthalmia-Associated Transcription Factor - genetics | Gene Expression Regulation, Neoplastic - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights